Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 08:32 am Sale | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Deep Track Capital LP | 0 0% | -3,952,000 (Position Closed) | View |
| 2024-02-06 09:02 am Purchase | 13G | ACUMEN PHARMACEUTICALS INC ABOS | FRANKLIN RESOURCES INC BEN | 3,358,809 5.8% | 3,358,809 (New Position) | View |
| 2024-01-24 4:22 pm Purchase | 13G | ACUMEN PHARMACEUTICALS INC ABOS | MURRAY JAMES B JR | 2,681,057 4.6% | 100,000 (+3.87%) | View |
| 2023-07-25 4:31 pm Purchase | 13D | ACUMEN PHARMACEUTICALS INC ABOS | RA CAPITAL MANAGEMENT L.P. | 14,981,618 25.9% | 5,207,067 (+53.27%) | View |
| 2023-02-14 4:24 pm Sale | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Manning Paul B | 3,205,128 7.8% | -805,550 (-20.09%) | View |
| 2023-02-14 3:25 pm Purchase | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Sands Capital Ventures LLC | 3,417,075 8.3% | 3,417,075 (New Position) | View |
| 2023-02-14 08:21 am Purchase | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Deep Track Capital LP | 3,952,000 9.66% | 1,537,083 (+63.65%) | View |
| 2022-10-07 2:58 pm Sale | 13G | ACUMEN PHARMACEUTICALS INC ABOS | BlackRock Inc. BLK | 1,115,027 2.8% | -1,994,643 (-64.14%) | View |
| 2022-02-16 4:25 pm Purchase | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Hardie Molly G. | 3,451,152 8.5% | 3,451,152 (New Position) | View |
| 2022-02-14 7:27 pm Purchase | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Manning Paul B | 4,010,678 9.9% | 4,010,678 (New Position) | View |
| 2022-02-14 4:03 pm Purchase | 13G | ACUMEN PHARMACEUTICALS INC ABOS | MURRAY JAMES B JR | 2,581,057 6.4% | 2,581,057 (New Position) | View |
| 2022-02-04 4:12 pm Purchase | 13G | ACUMEN PHARMACEUTICALS INC ABOS | BlackRock Inc. BLK | 3,109,670 7.7% | 3,109,670 (New Position) | View |
| 2022-01-27 4:34 pm Purchase | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Deep Track Capital LP | 2,414,917 5.97% | 2,414,917 (New Position) | View |
| 2021-09-13 4:30 pm Purchase | 13D | ACUMEN PHARMACEUTICALS INC ABOS | RA CAPITAL MANAGEMENT L.P. | 9,774,551 24.2% | 3,778 (+0.04%) | View |
| 2021-07-16 4:30 pm Purchase | 13D | ACUMEN PHARMACEUTICALS INC ABOS | RA CAPITAL MANAGEMENT L.P. | 9,770,773 25.3% | 9,770,773 (New Position) | View |
| 2021-07-12 9:08 pm Purchase | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Sands Capital Ventures Discovery Fund III L.P. | 3,417,075 8.84% | 3,417,075 (New Position) | View |